| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.47▼ | 1.48▼ | 1.48▼ | 1.43▲ | 1.64▼ |
| MA10 | 1.47▼ | 1.46▲ | 1.45▲ | 1.45▲ | 1.69▼ |
| MA20 | 1.45▲ | 1.46▲ | 1.46▲ | 1.65▼ | 1.88▼ |
| MA50 | 1.46▲ | 1.45▲ | 1.46▲ | 1.74▼ | 1.87▼ |
| MA100 | 1.46▲ | 1.54▼ | 1.64▼ | 1.85▼ | 1.17▲ |
| MA200 | 1.61▼ | 1.70▼ | 1.72▼ | 2.00▼ | 1.40▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.005▲ | 0.006▲ | -0.015▼ | -0.075▼ |
| RSI | 51.545▲ | 50.986▲ | 50.264▲ | 42.628▼ | 43.706▼ |
| STOCH | 56.966 | 82.698▲ | 77.273 | 23.730 | 21.677 |
| WILL %R | -46.667 | -31.818 | -31.818 | -83.088▼ | -91.667▼ |
| CCI | 15.253 | 29.242 | 10.294 | -34.532 | -106.060▼ |
|
Friday, April 03, 2026 12:02 PM
IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative γδ T cell therapies for cancer and autoimmune diseases, today ...
|
|
Tuesday, February 24, 2026 12:00 AM
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies for cancer and autoimmune ...
|
|
Monday, February 09, 2026 11:37 AM
I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be IN8bio (INAB). The reason why I want to go over this biotech next is because it reported ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/04/26 | 1.485 | 1.50 | 1.45 | 1.465 | 41,529 |
| 07/04/26 | 1.38 | 1.4539 | 1.38 | 1.43 | 20,663 |
| 06/04/26 | 1.45 | 1.50 | 1.41 | 1.41 | 61,461 |
| 02/04/26 | 1.37 | 1.4573 | 1.3501 | 1.44 | 19,053 |
| 01/04/26 | 1.455 | 1.46 | 1.38 | 1.40 | 60,536 |
| 31/03/26 | 1.38 | 1.51 | 1.38 | 1.48 | 73,327 |
| 30/03/26 | 1.42 | 1.49 | 1.36 | 1.37 | 42,268 |
| 27/03/26 | 1.48 | 1.54 | 1.35 | 1.41 | 87,936 |
| 26/03/26 | 1.55 | 1.55 | 1.45 | 1.47 | 77,316 |
| 25/03/26 | 1.55 | 1.6599 | 1.50 | 1.61 | 190,713 |
|
|
||||
|
|
||||
|
|